EN
- Bifidobacterium breve CCFM1025
- Bifidobacterium infantis CCFM687
- Pediococcus acidilactici CCFM6432
- 1) Antidepressant and Improve sleep
- 2) Antidepressant and Improve Metabolism and Cognition
- 3) Improve the mood, gastrointestinal function, and sleep of patients with depression, and increase the intestinal lactate content
HelpNeuro™ Mental Health - Relieve Anxiety
Formulation
Functionality
Scientific Support
Human clinical trial
1) Bifidobacterium breve CCFM1025 Attenuates Major Depression Disorder via Regulating Gut Microbiome and Tryptophan Metabolism: A Randomized Clinical Trial.
2) Multi-Probiotics ameliorate Major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation.
Patent
1) Jiangnan University,A strain of Bifidobacterium breve that relieving Alzheimer's disease Chinese Invention Patent, Granted Publication Number CN112972502B/en.
2) Jiangnan University, A strain of Bifidobacterium longum subspecies infantis that Improve depressive-like behaviors in mice with depression and increase the levels of 5-hydroxytryptamine and brain-derived neurotrophic factor in the brains of mice with depression.Chinese Invention Patent, Granted Publication Number CN109055269B/en.
3) Jiangnan University,A strain of Pediococcus acidilactici that disclosure can be used to prepare food, health-care products and drugs with the functions of resisting depression, resisting inflammation, resisting inflammatory bowel disease, resisting obesity and resisting type I diabetes.Chinese Invention Patent, Granted Publication Number US12419918B2.